A Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft Versus Host Disease
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Incyte Corporation
Start Date
July 2, 2019
End Date
February 27, 2024
Administered By
Duke Cancer Institute
Awarded By
Incyte Corporation
Start Date
July 2, 2019
End Date
February 27, 2024